ELEM Biotech

About:

Alya Red is a “virtual human” designed to optimise medical treatments for patients to improve and extend their lives.

Website: https://elem.bio/

Twitter/X: ELEM_Biotech

Top Investors: European Innovation Council

Description:

ELEM is a start-up company conceived at the Barcelona Supercomputing Center (BSC) and host of MareNostrum supercomputer. ELEM is co-founded by BSC researchers Mariano Vázquez, Guillaume Houzeaux, José María Cela, and business consultant Chris Morton. The company has developed Alya Red, a set of simulation tools, which following a “Software-as-a-Service” model deployed in the cloud, focuses on medical devices and pharmaceutical industries. Alya Red simulates cardiovascular or respiratory systems on “virtual patients”. Combining high performance computing, computational biomechanics and data analysis, these computational avatars can be used by biomedical sector companies and clinicians to elaborate diagnoses, plan treatments, improve drug delivery and action, optimise medical devices, etc. ELEM headquarters are in Barcelona.

Total Funding Amount:

3.68M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2018-01-01

Contact Email:

contact(AT)elem.bio

Founders:

Mariano Vazquez

Number of Employees:

11-50

Last Funding Date:

2022-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai